セルスペクト株式会社
Morioka, JP · 3 known investors
Find your way into セルスペクト株式会社
Sign up to see every warm intro you have to セルスペクト株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the セルスペクト株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.
Founders & leadership
TI

Takuya Iwabuchi代表取締役兼CEO (Representative Director & CEO)
WH
Wataru HojoExecutive Officer & CTO
Investors · 3
Frequently asked questions
- What does セルスペクト株式会社 do?
- Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.
- Who founded セルスペクト株式会社?
- セルスペクト株式会社 was founded by Takuya Iwabuchi.
- Who are セルスペクト株式会社's investors?
- セルスペクト株式会社's investors include Tokyo University of Science Innovation Capital, Iwagin Business Creation Capital, Mitsubishi UFJ Capital.
- Where is セルスペクト株式会社 headquartered?
- セルスペクト株式会社 is headquartered in Morioka, JP.